S D Flynn
Overview
Explore the profile of S D Flynn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
352
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pando J, McLean R, Flynn S, Duffy T
J Clin Rheumatol
. 2008 Dec;
1(2):125-7.
PMID: 19077960
Up to 10% of patients with myelodysplastic syndrome (MDS) may have arthralgias as a feature of their disease. All patients with MDS have the potential to progress into acute leukemia....
2.
Troiano R, Flynn S, McCarthy S
J Magn Reson Imaging
. 1998 Dec;
8(6):1198-202.
PMID: 9848728
Adenomyosis of the uterus is most often seen as focal or diffuse thickening of the myometrial junctional zone on MRI. We describe the morphologic features and signal characteristics of the...
3.
Troiano R, Lazzarini K, Scoutt L, Lange R, Flynn S, McCarthy S
Radiology
. 1997 Sep;
204(3):795-8.
PMID: 9280262
Purpose: To describe the morphologic and signal intensity characteristics on magnetic resonance (MR) images of fibromas and fibrothecomas. Materials And Methods: MR images of 11 female patients with histologically proved...
4.
Fezza J, Wolfley D, Flynn S
J Pediatr Ophthalmol Strabismus
. 1997 Mar;
34(2):128-31.
PMID: 9083963
No abstract available.
5.
Murren J, Anderson S, Fedele J, Pizzorno G, Belliveau D, Zelterman D, et al.
J Clin Oncol
. 1997 Jan;
15(1):148-57.
PMID: 8996136
Purpose: Based on preclinical data that demonstrated synergy between alkylating agents and topoisomerase (topo) I poisons, we determined the maximum-tolerated dose (MTD) of topotecan, using a 5 day bolus schedule,...
6.
Mitchell B, Cornelius E, Zoghbi S, Murren J, Ghoussoub R, Flynn S, et al.
Surgery
. 1996 Dec;
120(6):1039-45.
PMID: 8957492
Background: Localization of parathyroid glands is critical in the treatment of recurrent or persistent hyperparathyroidism. Technetium sestamibi imaging may improve localization; however, the mechanism of visualization of parathyroid tissue remains...
7.
DiGiovanna M, Carter D, Flynn S, Stern D
Br J Cancer
. 1996 Sep;
74(5):802-6.
PMID: 8795585
Overexpression of HER-2/neu in human breast carcinomas correlates with poor prognosis, although its strength as a prognostic indicator varies widely in different reports. Variability may be due to active signalling...
8.
Murren J, Durivage H, Buzaid A, Reiss M, Flynn S, Carter D, et al.
Cancer Chemother Pharmacol
. 1996 Jan;
38(1):65-70.
PMID: 8603454
Overexpression of P-glycoprotein (P-gp) has been implicated as the mechanism of multidrug resistance (MDR) in a number of human cancers, including carcinoma of the breast. We conducted a clinical trial...
9.
Wong T, Suster S, Bouffard D, Flynn S, Johnson R, Barnhill R, et al.
Int J Dermatol
. 1995 May;
34(5):323-9.
PMID: 7607792
Background: Cutaneous manifestations of myeloid leukemia can be specific or nonspecific. The study was designed to determine the prevalence and histologic appearance of cutaneous lesions in patients with myeloid leukemia...
10.
Reale M, Yen Y, Strair R, Flynn S, Cooper D
South Med J
. 1995 Apr;
88(4):462-4.
PMID: 7536347
Therapy with myeloid colony-stimulating factors has been safely and effectively used in a wide variety of situations associated with neutropenia. We present a case of pseudoleukemia occurring in a patient...